Aeropay | $20,000,000 | (May 17, 2024)
Bedrock Materials | $9,000,000 | (May 17, 2024)
OTPLESS | $3,500,000 | (May 17, 2024)
Bcv
France
- Paris, Île-de-France
- 14/12/2023
- Series A
- $6,529,000
Bcv is a french Medtech company spin-off from the Intelligent Robotic Systems Laboratory (ISIR) at Sorbonne University and the Rothschild Foundation Hospital in Paris.
A multidisciplinary team developing innovative technologies for endovascular procedures, for immediate improvement and future applications.
Our first focus? STROKE
Discover our actuable guidewire with electronically controllable shape-ability designed for the interventional neuroradiology procedures.
Objective? Enhance endovascular access & navigation in any anatomy.
Our first-ever Shape Memory Alloy actuated system is :
- Suitable for minimally invasive interventions,
- Unique, a single solution that could replace the package of traditional devices,
- Ergonomic, its unique smart handle allows electronic actuation and a controllable torque of the catheter tip robotically to conform to arterial tortuosities,
- Compatible and complementary with Robotics and Image Guided Therapy, in a patient-oriented specific design.
Objective ? Reach the most complex parts of the human body, providing a game-changer solution for endovascular minimally-invasive procedures.
Caution: Investigational device, not yet available for commercial sale, worldwide.
- Industry Medical Device
- Website https://www.basecampvascular.com/
- LinkedIn https://www.linkedin.com/company/basecamp-vascular/about/
Related People
Thierry COLFounder
France -
Paris, Île-de-France
20 years experience in international MedTech emerging and mature markets with a proven track record. As a Chief Operating Officer, I co-led with the transformation of a Small and Medium Company to a Mid Size International one. With strong business skills, I drove internal sales and operations teams and developed a distribution network to reach outstanding results in different regions such as Europe, Middle East, Africa and Asia. Moreover, I co-managed the acquisition, integration and development of several synergistic international companies over the years under LBO.
#medical devices;#cardiovascular;#digestive;#healthcare; #strategy; #M&A; #merger; #acquisition; #supplychain; #distribution; #CorporateOfficer
ekko | $2,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
HEPHAISTOS-Pharma | $11,189,199 | (May 17, 2024)
Keyper | $4,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
Angel AI | $4,750,000 | (May 17, 2024)
InstaAstro | $2,300,000 | (May 17, 2024)
Fay | $25,000,000 | (May 16, 2024)